エピディディムスタンパク質4のレベルは,エジェクション分子が保存された心不全の患者に悪い予後に関連しています

Yi Tang¹, Yu Chen², Xiao Jiao Huang²

¹Department of Cardiology, Hunan Provincial People's Hospital, The First Affiliated Hospital of Hunan Normal University, Clinical Medicine Research Center of Heart Failure of Hunan Province, Hunan Normal University, Changsha, China.

Frontiers in cardiovascular medicine

|September 3, 2025

まとめ

人間の頭皮のタンパク質4 (HE4) は,心不全の有害な結果を予測する. HE4濃度の上昇は,心不全の再入院と心血管疾患による死亡のリスクの増加と関連しています.

科学分野:

心臓病科
バイオマーカー
心不全研究

背景:

発射分数保存 (HFpEF) による心不全は重大な臨床的課題である.
HFpEFにおけるヒト先頭葉のタンパク質4 (HE4) の予後値は,大部分未定のままである.
HFpEFの予後のための信頼性の高いバイオマーカーを特定することは,患者の管理に極めて重要です.

研究の目的:

HFpEFと診断された患者の血清HE4値の予後的意義を調査する.
この患者集団において,再入院および死亡率を含む不良心血管疾患を HE4 が予測できるかどうかを判断する.

主な方法:

2021年1月から2022年8月までの170人のHFpEF患者の入院予定
血清のHE4濃度は,化学発光微粒子の免疫測定法を使用して定量化されました.
心不全再入院および心血管疾患による死亡を含むエンドポイントイベントは,平均18ヶ月間追跡された.

主要な成果:

多変量コックス回帰では,HE4がエンドポイントイベントの独立した予測因子 (HR=1. 009,P=0. 010) として特定されました.
HE4 > 42. 45 pmol/ L (HR=2. 66, P< 0. 01) の患者では,カプラン- メイア解析により,著しく高いイベントリスクが示されました.
調整した分析により,HE4の予測値が確認された (HR=2. 48,P<0. 05).

結論:

血清HE4は,HFpEF患者における有害な結果の独立した予測因子である.
HE4濃度の上昇は,心不全再入院と心血管疾患による死亡のリスクの増加と関連しています.
HE4はHFpEF管理において貴重な予後バイオマーカーとして機能する.

キーワード:

バイオマーカー発射分子が保存された心不全繊維症ヒトの頭皮のタンパク質 4 予後について

さらに関連する動画

07:09

A Surgical Model of Heart Failure with Preserved Ejection Fraction in Tibetan Minipigs

Published on: February 18, 2022

2.0K

05:16

Cutoff Value of Phase Angle by Bioelectrical Impedance Analysis at Admission as a Prognostic Factor in Patients with Acute Heart Failure

Published on: June 10, 2025

213

関連する概念動画

01:17

Pathophysiology of Heart Failure

1.8K

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...

1.8K

01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...

01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...

01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

213

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...

213

01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...

01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...

関連する実験動画